Screener
Citius Pharmaceuticals CTXR Q2 2026 earnings
Reported August 14, 2026 · After market close
Revenue$1.5MMiss by $4.0M
EPS-$0.34Beat by $0.02
Revenue estimate$5.5M
EPS estimate-$0.36
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
FAQ
- When did Citius Pharmaceuticals report Q2 2026 earnings?
- Citius Pharmaceuticals (CTXR) reported Q2 2026 earnings on August 14, 2026 after market close.
- What were Citius Pharmaceuticals's Q2 2026 revenue and EPS?
- Citius Pharmaceuticals reported revenue of $1.5M and eps of $-0.34 for Q2 2026.
- Did Citius Pharmaceuticals beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $5.5M by $4.0M. EPS beat the consensus estimate of $-0.36 by $0.02.
- How did Citius Pharmaceuticals's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 57.5% from $-0.80.
- Where can I find Citius Pharmaceuticals's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001213900-26-090181) and the 10-Q periodic report (0001213900-26-090185) directly on SEC EDGAR. The filing index links above go to sec.gov.
